GRI BIO, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
GRI BIO, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • GRI BIO, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $37K, a 185% increase year-over-year.
  • GRI BIO, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $436K.
  • GRI BIO, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $388K, a 1452% increase from 2022.
  • GRI BIO, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $25K, a 96% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $436K $37K +$24K +185% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $412K $37K +$24K +185% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $388K $36K +$192K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $196K $326K +$326K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$130K $13K +$13K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$143K $13K -$168K -92.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $25K -$156K -$782K -125% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $807K $0 -$134K -100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $941K $0 -$138K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.08M $181K +$13K +7.74% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.07M $626K +$472K +306% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-14
Q3 2021 $594K $134K +$82K +158% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $512K $138K +$110K +393% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $402K $168K +$133K +380% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $269K $154K Oct 1, 2020 Dec 31, 2020 10-K 2022-02-14
Q3 2020 $52K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $28K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $35K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.